Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ Xiao, G. He, T. Zhang, B. Yang, Z. Ling, N. Chen, M. Zhang, D. Hu, P. Zhang, G. Peng, M. Cai, D. Ren, H.

Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Pang, Y. Cao, D. Zhu, X. Long, Q. Tian, F. Long, X. Li, Y.

Safety and Efficacy of the Modified Vaccinia Ankara-Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Santangelo, O. E. Provenzano, S. Vella, C. Fermi, S. Facchini, L. Rizzo, M. Brighina, F. Cedrone, F. Firenze, A.

Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review

  • All age groups
  • COVID-19
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Yellow fever
  • Varicella
  • Tetanus
  • Tick-borne encephalitis
  • Diphtheria
  • Pertussis
  • Meningococcal disease
  • Pneumococcal disease
  • Rabies
  • Haemophilus influenzae type B
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Mohamed Taha, A. Abouelmagd, K. Mahmoud, A. M. Elkasaby, M. H. Nguyen, D. Ahmed, R. Patel, P. Bonilla-Aldana, D. K. Luna, C. Rodriguez-Morales, A. J.

Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis

  • Newborn
  • Children
  • Typhoid
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Gerede, A. Daskalakis, G. Mikos, T. Chatzakis, C. Vavoulidis, E. Eleftheriades, M. Domali, E. Nikolettos, K. Oikonomou, E. Antsaklis, P. Theodora, M. Psarris, A. Margioula-Siarkou, C. Petousis, S. Stavros, S. Potiris, A. Athanasiadis, A. Dinas, K. Tsikouras, P. Nikolettos, N. Sotiriadis, A.

Safety of COVID-19 Vaccination in Pregnancy: A Systematic Review

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Tee, Q. W. Odisho, R. Purcell, E. Purcell, R. Buttery, J. Nold-Petry, C. A. Nold, M. F. Malhotra, A.

Safety of Hepatitis B Vaccines (Monovalent or as Part of Combination) in Preterm Infants: A Systematic Review

  • Newborn
  • Hepatitis B
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Schell, T. L. Fass, L. Hitchcock, M. E. Farraye, F. A. Hayney, M. S. Saha, S. Caldera, F.

Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review

  • Newborn
  • Rotavirus
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Ning, F. Cao, X. Q. Wang, Q. Q. Li, Z. Y. Ruan, Z. Chang, T.

Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Dhanasekaran, P. Karasu, B. T. Mak, A.

Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Qi, Y. Zheng, H. Wang, J. Chen, Y. Guo, X. Li, Z. Zhang, W. Zhou, J. Wang, S. Lin, B. Zhang, L. Yan, T. Clemens, J. Xia, J. An, Z. Yin, Z. Wang, X. Feng, Z.

Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...